Dried Purple Laver (Nori) as a Food Source of Vitamin B12 in Vegetarians

May 30, 2023 updated by: Tina Hsueh-Ting Chiu, Fu Jen Catholic University

The Bioavailability of Vitamin B12 From Nori in Vegetarians: a Dose Response Study

This is an intervention study aiming to understand the bioavailability of vitamin B12 from nori for vegetarians.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Thirty vegetarian participants will be randomly assigned to one of three intervention arms: (1) 5g of nori (4 sheets, containing 2.4μg vitamin B12), (2) 8g nori (7 sheets, containing 4μg vitamin B12), (3) control group (no nori). At baseline and end of 4 weeks, participants will be measured on serum vitamin B12, methylmalonic acid, holotranscobalamin, homocysteine and folate.

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • New Taipei City, Taiwan, 24205
        • Department of Nutritional Science, Fu-Jen Catholic University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 56 years (Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Vegetarians (including vegan, ovo-vegetarian, lacto-vegetarian, lacto-ovo vegetarian)
  • Duration of the vegetarian diet: at least 1 year
  • Aged 20-60 years old
  • Have not taken vitamin B12 or folate supplement within 1 year
  • Willing to adhere to study intervention and be tested for vitamin B12 related biomarkers.
  • Familiar with LINE application on smartphone

Exclusion Criteria:

  • Any disease or surgery that affects the vitamin B12 status (Pernicious anemia, Gastrointestinal disease and surgery, Pancreatic diseases, Chronic kidney disease)
  • Hyperthyroidism
  • Previous adverse reaction to nori
  • Have taken antacid or metformin in the past 1 week
  • Alcoholic and not willing to abstinence from alcoholic beverages

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control
No intervention
Experimental: 2.4μg vitamin B12
Participants need to consume 4 sheets (5g) of dried purple laver (Nori) daily for 4 weeks.
Dried purple laver (Nori) that has been test to have bioactivity vitamin B12 will be given for intervention groups.
Experimental: 4μg vitamin B12
Participants need to consume 7 sheets (8g) of dried purple laver (Nori) daily for 4 weeks.
Dried purple laver (Nori) that has been test to have bioactivity vitamin B12 will be given for intervention groups.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in holotranscobalamin in 4 weeks
Time Frame: 4 weeks (Week 4 - Baseline)
Assessing the change in serum holotranscobalamin after consuming varying doses of nori
4 weeks (Week 4 - Baseline)
Change in methylmalonic acid in 4 weeks
Time Frame: 4 weeks (Week 4 - Baseline)
Assessing the change in serum methylmalonic acid after consuming varying doses of nori
4 weeks (Week 4 - Baseline)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in serum vitamin B12 concentration in 4 weeks
Time Frame: 4 weeks (Week 4 - Baseline)
Assessing the change in serum vitamin B12 after consuming varying doses of nori
4 weeks (Week 4 - Baseline)
Change in homocysteine in 4 weeks
Time Frame: 4 weeks (Week 4 - Baseline)
Assessing the change in serum homocysteine after consuming varying doses of nori
4 weeks (Week 4 - Baseline)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Tina Hsueh-Ting Chiu, PhD, Fu-Jen Catholic University, Department of Nutritional Science

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 7, 2022

Primary Completion (Actual)

March 31, 2023

Study Completion (Actual)

March 31, 2023

Study Registration Dates

First Submitted

November 4, 2022

First Submitted That Met QC Criteria

November 10, 2022

First Posted (Actual)

November 14, 2022

Study Record Updates

Last Update Posted (Actual)

June 1, 2023

Last Update Submitted That Met QC Criteria

May 30, 2023

Last Verified

May 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Vitamin B 12 Deficiency

Clinical Trials on Dried purple laver (Nori)

Subscribe